Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Tönges

Showing results (1-10 of 131) with videos related to

Pageof 14
Sort By:
Der Nervenarzt|August 2, 2024
[Facets of neurodegeneration : The fine art of diagnostic workup and individualized treatment]Lars Tönges
Brain Sciences|July 27, 2022
SARS-CoV-2, COVID-19 and NeurodegenerationLars Tönges, Stephan Klebe
Neural Regeneration Research|March 1, 2021
Short-chain fatty acids in the context of Parkinson's diseaseJudith Metzdorf, Lars Tönges
Der Nervenarzt|May 16, 2024
[Multidisciplinary Complex Treatment of Parkinson's disease : Cornerstone of an individualized treatment]Raphael Scherbaum, Lars Tönges
Fortschritte Der Neurologie-Psychiatrie|February 28, 2022
[Adenosine A2A Receptor Antagonists as a Treatment Option for Parkinson's Disease?]Wolfgang H Jost, Lars Tönges
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2019
CSF Sample Preparation for Data-Independent AcquisitionKatalin Barkovits, Lars Tönges, Katrin Marcus
Movement Disorders Clinical Practice|August 11, 2020
Emergence of Bruxism after Reducing Left Pallidal Stimulation in a Patient with Huntington's DiseaseDaniel Richter, Carsten Saft, Lars Tönges
Movement Disorders Clinical Practice|July 7, 2020
Comment on: A 57-Year-Old Woman With Progressive Left Hand Clumsiness and FallsDaniel Richter, Lars Tönges, Christos Krogias
Neural Regeneration Research|July 11, 2019
Antibody-based immunotherapies for Parkinsonian syndromesLars Tönges, Maria Angela Samis Zella
Fortschritte Der Neurologie-Psychiatrie|July 18, 2018
[Parkinson's disease and neuroinflammation - Cellular pathology, mechanisms and therapeutic options]Lars Tönges, Judith Metzdorf, Samis Zella
Pageof 14

Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
Der Nervenarzt|August 2, 2024
[Facets of neurodegeneration : The fine art of diagnostic workup and individualized treatment]Lars Tönges
Brain Sciences|July 27, 2022
SARS-CoV-2, COVID-19 and NeurodegenerationLars Tönges, Stephan Klebe
Neural Regeneration Research|March 1, 2021
Short-chain fatty acids in the context of Parkinson's diseaseJudith Metzdorf, Lars Tönges
Der Nervenarzt|May 16, 2024
[Multidisciplinary Complex Treatment of Parkinson's disease : Cornerstone of an individualized treatment]Raphael Scherbaum, Lars Tönges
Fortschritte Der Neurologie-Psychiatrie|February 28, 2022
[Adenosine A2A Receptor Antagonists as a Treatment Option for Parkinson's Disease?]Wolfgang H Jost, Lars Tönges
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2019
CSF Sample Preparation for Data-Independent AcquisitionKatalin Barkovits, Lars Tönges, Katrin Marcus
Movement Disorders Clinical Practice|August 11, 2020
Emergence of Bruxism after Reducing Left Pallidal Stimulation in a Patient with Huntington's DiseaseDaniel Richter, Carsten Saft, Lars Tönges
Movement Disorders Clinical Practice|July 7, 2020
Comment on: A 57-Year-Old Woman With Progressive Left Hand Clumsiness and FallsDaniel Richter, Lars Tönges, Christos Krogias
Neural Regeneration Research|July 11, 2019
Antibody-based immunotherapies for Parkinsonian syndromesLars Tönges, Maria Angela Samis Zella
Fortschritte Der Neurologie-Psychiatrie|July 18, 2018
[Parkinson's disease and neuroinflammation - Cellular pathology, mechanisms and therapeutic options]Lars Tönges, Judith Metzdorf, Samis Zella
Pageof 14